“showed a trend”

In our study, increasing TEMMB showed a trend towards survival harm in these highly somatically-recurrent tumors.

PET imaging showed a trend toward enhanced midbrain dopaminergic activity.

Patients showed a trend in which reduced IS and OS thickness and sensitivity were observed; the small sample size and variability in sensitivity at regions with normal IS and OS thickness may have reduced the power to detect a significant correlation in patients.

Third, our subgroup analysis showed a trend toward a survival benefit for women among elderly subjects.

14 The nonrandomized use of WLI (n=44) showed a trend toward improved 3-year progression-free survival (PFS) of 37% vs 21% in this population, but this was not statistically significant ( P =0.18). 14 Nevertheless, WLI is generally well tolerated and is often utilized for those patients who can achieve second remission.

Thus, the study was underpowered to detect mortality benefit yet still showed a trend toward decreases in both 30-day readmission and 30-day mortality rates.

The TXA treatment group showed a trend toward lower blood transfusion rates over the peri- and postoperative period, though it did not reach statistical significance.

The Danish study showed a trend that the educational intervention had a positive impact on adherence to guidelines, but the findings were only significant for increased spirometry testing in a subgroup of practices identified as having a high potential for improvement.

VAF >10%), only high burden TP53 ab [including del(17p)] patients showed a trend for worse OS and significantly worse TFS compared to TP53 wt ( Figure 2A and B ) ( P =0.06 and P =0.01, respectively).

As in the study by Sekeres et al ., 21 we showed a trend towards improved responses without translation to improved clinical benefit or survival, though this study was not adequately powered to show a difference in overall survival.

Patients with more effective DMTs showed a trend towards decreased symptom burden of fatigue and depression.

We also detected the transcription of PTI-related genes in OsPT8 RNAi plants after treatment with the two PAMP elicitors, and transcription of these genes was similar to the level determined in wide-type NPB, which showed a trend similar to the expression analyses observed in the investigations of inoculation and defense genes (Fig.

Interestingly, also the jejunum, which was not in contact with the topically applied TNBS/ethanol, showed a trend for a higher basal I sc and a higher G t .

MT1A gene methylation showed a trend of being associated with higher mRNA expression level in astrocytomas.

Differences in CSF P-tau 181 and Aβ 1–42 /Aβ 1–40 between HC and AD dementia showed a trend towards statistical significance.

Postoperative cognitive function showed a trend of decreasing first and then increasing; the scores of cognitive function in both groups 1 day after surgery were at trough level, and recovered gradually from 3 days after surgery.

Male sex showed a trend towards worse outcome, but without reaching statistical significance (HR = 1.53; 95% CI 0.98–2.39; p = 0.06).

The GEE analysis showed a trend towards lower odds of unprotected sex with RFPs at the population level during the intervention phase, though this was not statistically significant.

The analysis also showed a trend for lower trabecular BV/TV in mice with excess GCs ( Crh +/−120 ) and no significant modification of BV/TV in Sost-Crh +/−120 mice ( Figure 2 A).

On the other hand, within the same time frame, IgG treatment showed a trend for increased tumor growth, as previously reported ( 29 ).

In contrast, IVIg showed a trend toward increased IFNγ production and secretion.

After the period of flooding, the soil from waterlogging treatments showed a trend of decreasing NH 4 + -N concentrations, but the NO 3 - -N and available P concentrations increased significantly.

Cisplatin increased the production of Th2-associated cytokine (IL-4), while HemoHIM treatment showed a trend to reduce secretion of IL-4 ( Figure 6 ). 3.6.

Recent posthoc analysis of canagliflozin also showed a trend toward higher rate of UTI in hot climate countries when compared with other areas (9.5% vs 4.6% at 26 weeks of placebo-controlled period, 22.3% v 7.4% at 104 weeks of active controlled period with canagliflozin 100 mg).[ 22 ] Second most common complaint which we noticed was feeling of weakness and lethargy and importantly this led to discontinuation of drug in 3.3% of patients.

SARM1 +/− mice showed a trend toward acceleration that did not reach statistical significance (median survival, 171 dpi; Fig. 2 C ).